STOK Performance: 419.7% Return (12 Months)

STOK returned 419.7% over 12 months, outperforming the S&P 500 (23.6%). Volatility: 77.0%.

RS IBD 54.64
Top 14% in Peers
Volatility 77.0%
Top 63% in Peers
Total Return 12m 419.68%
Top 7% in Peers
RS Rating 98.46
Top 14% in Peers
P/E
P/E Trailing 0.00
P/E Forward 204
High / Low 52w
52 Week High 38.35 USD
52 Week Low 5.90 USD
Sentiment
VRO Trend Strength ±100 16.68
Buy Signal ±3 -0.33
Drawdowns 3y
Max Drawdown 75.62%
Mean Drawdown 31.05%
Compare performance with 200 peers in Biotechnology
12m Total Return: STOK (419.7%) vs SPY (23.6%) Total Return of Stoke Therapeutics versus its related sector ETF SPY
5y Drawdown (Underwater) Chart 5 Year Drawdown / Underwater Chart for STOK Performance: 419.7% Return (12 Months)

Top Performer in Biotechnology (5/200)

Short Term Performance
SYMBOL 1W 1M 3M
ERAS 18.97% 26.31% 410.32%
DAWN 0.19% 113.86% 150.88%
TNGX 12.31% 88.09% 142.76%
DNTH 6.00% 55.26% 133.13%
ORKA 19.85% 62.33% 98.33%
STOK -0.33% -3.08% 0.58%
Long Term Performance
SYMBOL 6M 12M 5Y
ABVX 41.05% 1944.39% 920.43%
ABVX 40.44% 1781.26% 412.12%
TNGX 178.74% 1603.15% 96.82%
ERAS 635.95% 1371.90% 2.18%
PRAX 470.76% 832.07% -37.39%
STOK 28.09% 419.68% -17.61%
Overall Best Picks of Peer Group (GARP Metrics)
SYMBOL MCAP 1M 12M 5Y P/E P/E fwd PEG EPS stab EPS cagr
ROIV NASDAQ
Roivant Sciences		 19.9B 1.72% 183% 189% - - - 37.2% -14.4%
UTHR NASDAQ
United Therapeutics		 25.8B 13.3% 83.8% 193% 18.8 19.3 2.17 -2.20% -35.9%
DAWN NASDAQ
Day One Biopharmaceuticals		 2.21B 114% 178% -17.2% - - - 57.3% 49.0%
GLUE NASDAQ
Monte Rosa Therapeutics		 1.24B -4.84% 339% -19.3% - 10.0 - 59.8% 43.8%
KRYS NASDAQ
Krystal Biotech		 7.57B -1.08% 46.5% 231% 37.9 44.8 - 84.4% 26.5%
STRO NASDAQ
Sutro Biopharma		 79.1M 20.7% 301% -90.0% - 8.96 - -29.4% -68.0%
PHARM AS
Pharming		 1.18B 6.38% 100% 30.2% - 100 - -4.20% -
AUPH NASDAQ
Aurinia Pharmaceuticals		 1.90B 10.3% 93.9% 20.1% 6.89 20.5 - 63.8% 123%
TVTX NASDAQ
Travere Therapeutics		 2.51B 7.68% 83.8% 15.3% - 41.0 - 82.4% 24.9%
IRWD NASDAQ
Ironwood Pharmaceuticals		 572M -2.75% 160% -67.8% 23.4 12.3 -0.26 -58.4% -20.7%

Performance: STOK vs S&P 500

Total Return vs S&P 500
PERIOD STOK S&P 500 DIFFERENCE
1 Month -3.08% -3.34% 0.27%
3 Months 0.58% -4.38% 5.19%
6 Months 28.09% -1.44% 29.96%
12 Months 419.68% 23.60% 320.46%
5 Years -17.61% 72.80% -52.32%

STOK Performance FAQ

Does STOK outperform the market?

Yes, STOK significantly outperforms the market. Over the past 12 months, STOK returned 419.68% compared to 23.60% for the S&P 500.

What is the STOK return over the last 12 months?

STOK has returned 419.68% over the past 12 months, including dividends. Over 3 months the return was 0.58%, and over 5 years -17.61%.

How risky is STOK?

STOK has relatively low risk with a maximum drawdown of 75.62% over the past 3 years. The average drawdown is 31.05%.

STOK vs Sectors (12m)

Sorted by outperformance. Positive = STOK beats sector.

Relative Performance vs S&P Sectors
SECTOR ETF DIFFERENCE 12M
Consumer Staples XLP 417.1%
Health Care XLV 415.3%
Financials XLF 414.2%
Real Estate XLRE 414.2%
Consumer Discretionary XLY 405.6%
Consumer Discretionary XLY 405.6%
Communication Services XLC 397.5%
Materials XLB 396%
Industrials XLI 387.8%
Technology XLK 379.6%
Energy XLE 378.7%

STOK vs Asset Classes (12m)

Relative Performance vs Major Asset Classes
ASSET CLASS ETF DIFFERENCE 12M
S&P 500 SPY 320.46%
Gold GLD 369.8%
Long-Term Bonds TLT 420.9%